Literature DB >> 35333120

Loss of talin in cardiac fibroblasts results in augmented ventricular cardiomyocyte hypertrophy in response to pressure overload.

Natalie A Noll1, Lance A Riley1, Christy S Moore2, Lin Zhong2, Mathew R Bersi1, James D West2, Roy Zent2, W David Merryman1.   

Abstract

Pressure overload of the heart is characterized by concentric hypertrophy and interstitial fibrosis. Cardiac fibroblasts (CFs) in the ventricular wall become activated during injury and synthesize and compact the extracellular matrix, which causes interstitial fibrosis and stiffening of the ventricular heart walls. Talin1 (Tln1) and Talin2 (Tln2) are mechanosensitive proteins that participate in focal adhesion transmission of signals from the extracellular environment to the actin cytoskeleton of CFs. The aim of the present study was to determine whether the removal of Tln1 and Tln2 from CFs would reduce interstitial fibrosis and cardiac hypertrophy. Twelve-week-old male and female Tln2-null (Tln2-/-) and Tln2-null, CF-specific Tln1 knockout (Tln2-/-;Tln1CF-/-) mice were given angiotensin-II (ANG II) (1.5 mg/kg/day) or saline through osmotic pumps for 8 wk. Cardiomyocyte area and measures of heart thickness were increased in the male ANG II-infused Tln2-/-;Tln1CF-/- mice, whereas there was no increase in interstitial fibrosis. Systolic blood pressure was increased in the female Tln2-/-;Tln1CF-/- mice after ANG II infusion compared with the Tln2-/- mice. However, there was no increase in cardiac hypertrophy in the Tln2-/-;Tln1CF-/- mice, which was seen in the Tln2-/- mice. Collectively, these data indicate that in male mice, the absence of Tln1 and Tln2 in CFs leads to cardiomyocyte hypertrophy in response to ANG II, whereas it results in a hypertrophy-resistant phenotype in female mice. These findings have important implications for the role of mechanosensitive proteins in CFs and their impact on cardiomyocyte function in the pathogenesis of hypertension and cardiac hypertrophy.NEW & NOTEWORTHY The role of talins has been previously studied in cardiomyocytes; however, these mechanotransductive proteins that are members of the focal adhesion complex have not been examined in cardiac fibroblasts previously. We hypothesized that loss of talins in cardiac fibroblasts would reduce interstitial fibrosis in the heart with a pressure overload model. However, we found that although loss of talins did not alter fibrosis, it did result in cardiomyocyte and ventricular hypertrophy.

Entities:  

Keywords:  fibroblast; hypertrophy; talin

Mesh:

Substances:

Year:  2022        PMID: 35333120      PMCID: PMC9018049          DOI: 10.1152/ajpheart.00632.2021

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  44 in total

1.  The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation.

Authors:  D A Calderwood; R Zent; R Grant; D J Rees; R O Hynes; M H Ginsberg
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

Review 2.  From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.

Authors:  Alan H Gradman; Fadi Alfayoumi
Journal:  Prog Cardiovasc Dis       Date:  2006 Mar-Apr       Impact factor: 8.194

3.  Zasp regulates integrin activation.

Authors:  Mohamed Bouaouina; Klodiana Jani; Jenny Y Long; Stefan Czerniecki; Elizabeth M Morse; Stephanie J Ellis; Guy Tanentzapf; Frieder Schöck; David A Calderwood
Journal:  J Cell Sci       Date:  2012-09-19       Impact factor: 5.285

Review 4.  Hypertension as a risk factor for heart failure.

Authors:  Arun Kannan; Rajesh Janardhanan
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

5.  Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions.

Authors:  Francesco J Conti; Sue J Monkley; Malcolm R Wood; David R Critchley; Ulrich Müller
Journal:  Development       Date:  2009-09-30       Impact factor: 6.868

Review 6.  The pathogenesis of cardiac fibrosis.

Authors:  Ping Kong; Panagiota Christia; Nikolaos G Frangogiannis
Journal:  Cell Mol Life Sci       Date:  2013-05-07       Impact factor: 9.261

7.  Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.

Authors:  Yoshiro Maezawa; Tuncer Onay; Rizaldy P Scott; Lindsay S Keir; Henrik Dimke; Chengjin Li; Vera Eremina; Yuko Maezawa; Marie Jeansson; Jingdong Shan; Matthew Binnie; Moshe Lewin; Asish Ghosh; Jeffrey H Miner; Seppo J Vainio; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 10.121

8.  Impaired macrophage trafficking and increased helper T-cell recruitment with loss of cadherin-11 in atherosclerotic immune response.

Authors:  Camryn L Johnson; Lance Riley; Matthew Bersi; MacRae F Linton; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-09-10       Impact factor: 5.125

9.  Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin.

Authors:  Marina Theodosiou; Moritz Widmaier; Ralph T Böttcher; Emanuel Rognoni; Maik Veelders; Mitasha Bharadwaj; Armin Lambacher; Katharina Austen; Daniel J Müller; Roy Zent; Reinhard Fässler
Journal:  Elife       Date:  2016-01-27       Impact factor: 8.140

10.  Genetic lineage tracing defines myofibroblast origin and function in the injured heart.

Authors:  Onur Kanisicak; Hadi Khalil; Malina J Ivey; Jason Karch; Bryan D Maliken; Robert N Correll; Matthew J Brody; Suh-Chin J Lin; Bruce J Aronow; Michelle D Tallquist; Jeffery D Molkentin
Journal:  Nat Commun       Date:  2016-07-22       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.